Holen Sie sich die Stockscreener-App
14.49
2.42%
-0.36
Handel nachbörslich:
14.49
Schlusskurs vom Vortag:
$14.85
Offen:
$14.77
24-Stunden-Volumen:
26,934
Relative Volume:
0.39
Marktkapitalisierung:
$196.90M
Einnahmen:
$166.88M
Nettoeinkommen (Verlust:
$-74.18M
KGV:
-2.858
EPS:
-5.07
Netto-Cashflow:
$1.14M
1W Leistung:
-0.14%
1M Leistung:
+3.43%
6M Leistung:
-11.10%
1J Leistung:
-47.48%
1-Tages-Spanne:
$14.43
$15.04
1-Wochen-Bereich:
$14.27
$15.13
52-Wochen-Spanne:
$12.83
$29.11
Anika Therapeutics Inc Stock (ANIK) Company Profile
Firmenname
Anika Therapeutics Inc
Sektor
Telefon
(781) 457-9000
Adresse
32 WIGGINS AVENUE, BEDFORD, MA
Vergleichen Sie ANIK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
14.49 | 196.90M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
158.06 | 68.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.38 | 47.71B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.63 | 46.12B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.39 | 18.55B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.70 | 13.40B | 2.76B | 1.11B | 898.10M | 22.77 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-17 | Eingeleitet | B. Riley Securities | Buy |
| 2024-11-01 | Bestätigt | Barrington Research | Outperform |
| 2023-08-14 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | Fortgesetzt | Stephens | Equal-Weight |
| 2022-03-09 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | Eingeleitet | Stephens | Overweight |
| 2021-07-16 | Eingeleitet | UBS | Neutral |
| 2020-12-16 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-01-10 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | Eingeleitet | BWS Financial | Sell |
| 2019-09-24 | Bestätigt | Barrington Research | Outperform |
| 2019-09-23 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | Herabstufung | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2018-07-27 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | Bestätigt | Barrington Research | Outperform |
| 2016-05-09 | Hochstufung | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Anika Therapeutics Inc Aktie (ANIK) Neueste Nachrichten
Is the Options Market Predicting a Spike in Anika Therapeutics Stock? - TradingView
Invesco Ltd. Has $452,000 Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Anika Therapeutics (ANIK) Projected to Post Quarterly Earnings on Friday - Defense World
Envestnet Asset Management Inc. Lowers Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Geode Capital Management LLC Has $5.32 Million Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
JPMorgan Chase & Co. Raises Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika to Issue First Quarter 2025 Financial Results on Friday, M - GuruFocus
Anika Therapeutics to Announce First Quarter 2025 Financial Results on May 9, 2025 - Nasdaq
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 - GlobeNewswire
Anika Earnings Preview: Joint Preservation Giant Reveals Q1 2025 PerformanceKey Metrics to Watch - Stock Titan
Anika Therapeutics (NASDAQ:ANIK) Upgraded at B. Riley - Defense World
B. Riley Initiates Coverage on Anika Therapeutics (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - MSN
B. Riley Initiates Anika Therapeutics at Buy With $21 Price Target - marketscreener.com
Anika Therapeutics (ANIK) Receives 'Buy' Rating with $21 Target from B. Riley Analyst | ANIK Stock News - GuruFocus
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Purchased by Wellington Management Group LLP - Defense World
Viscosupplementation Market Is Booming Worldwide 2025-2032 | - openPR.com
Arrowstreet Capital Limited Partnership Has $979,000 Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Bought by American Century Companies Inc. - Defense World
Anika Therapeutics announces COO departure, streamlines management By Investing.com - Investing.com Canada
Anika Therapeutics announces COO departure, streamlines management - Investing.com
Anika Therapeutics Announces COO Departure and Role Elimination - TipRanks
Viscosupplementation Market Outlook: Growth Drivers - openPR.com
Anika Therapeutics stock hits 52-week low at $13.7 - Investing.com Australia
Anika Therapeutics stock hits 52-week low at $13.7 By Investing.com - Investing.com South Africa
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Anika Grants 3,800 Share Options to New Hire: Key Details Revealed - Stock Titan
Anika Therapeutics, Inc. (NASDAQ:ANIK) Position Trimmed by HighTower Advisors LLC - Defense World
Are Options Traders Betting On A Big Move In Anika Therapeutics (ANIK) Stock? - Barchart.com
Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock? - TradingView
Viscosupplementation Market Is Booming Worldwide | Anika - openPR.com
Europe Viscosupplementation Market Projected To Witness - openPR.com
Anika Therapeutics stock hits 52-week low at $14.9 By Investing.com - Investing.com South Africa
Anika Therapeutics stock hits 52-week low at $14.9 - Investing.com India
How the (ANIK) price action is used to our Advantage - news.stocktradersdaily.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) Stock Position Reduced by Charles Schwab Investment Management Inc. - Defense World
Hammertoe Solution Market Size, Trends 2031 By Key Players- - openPR.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Bank of New York Mellon Corp - Defense World
Europe Viscosupplementation Market Set to Witness Significant - openPR.com
Reviewing Anika Therapeutics (NASDAQ:ANIK) and InspireMD (NYSE:NSPR) - Defense World
Anika Therapeutics Faces Financial Strain Amid Geopolitical Tensions and Supply Chain Disruptions - TipRanks
Finanzdaten der Anika Therapeutics Inc-Aktie (ANIK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anika Therapeutics Inc-Aktie (ANIK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
| Nunes Anne | SVP, Chief Operations Officer |
Oct 01 '24 |
Option Exercise |
0.00 |
2,491 |
0 |
14,211 |
1.20%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):